Skip to main content
DNA Labs India

CIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic Test

Short Name: CIITA Gene BLS2A NGS Genetic Test

Also known as: Bare Lymphocyte Syndrome Type 2A, BLS2A, CIITA-related immunodeficiency

CIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS, Next-Generation Sequencing on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to diagnose Bare Lymphocyte Syndrome Type 2A (BLS2A) by detecting pathogenic mutations in the CIITA gene using next-generation sequencing (NGS). It helps confirm the genetic basis of immunodeficiency, guide treatment decisions, and facilitate family genetic counseling.

Test Code
4856
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
NGS, Next-Generation Sequencing
Step 1

Sample Collection

No special preparation required. Provide clinical history and family pedigree information during genetic counseling.

Method: Venipuncture or DNA extraction

Step 2

Laboratory Analysis

Blood sample collected via venipuncture or DNA extracted from provided sample. Minimal discomfort expected.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bruising. Resume normal activities.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Undergo genetic counseling to discuss test implications and provide family history.
2
During the Test:Sample collection and processing in the laboratory using NGS technology.
3
After the Test:Receive results via online portal, email, or WhatsApp. Follow up with genetic counseling for interpretation.

About This Test

Who Should Get This Test

The purpose of this test is to diagnose Bare Lymphocyte Syndrome Type 2A (BLS2A) by detecting pathogenic mutations in the CIITA gene using next-generation sequencing (NGS). It helps confirm the genetic basis of immunodeficiency, guide treatment decisions, and facilitate family genetic counseling.

How to Prepare

  • Ensure proper identification and labeling of samples
  • Use sterile collection tubes or FTA cards as specified
  • Transport samples at ambient temperature unless otherwise instructed

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is essential for diagnosing rare immunodeficiency disorders like BLS2A, enabling early intervention and personalized care plans."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs required
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or DNA extraction

Sample Stability

Blood samples: Stable for 48 hours at room temperature
Extracted DNA: Stable for longer periods if stored properly
Sample Rejection Criteria:
  • Hemolyzed or clotted samples
  • Insufficient sample volume
  • Improper labeling or documentation

Understanding Your Results

Results indicate the presence or absence of pathogenic mutations in the CIITA gene. A positive result confirms BLS2A, while a negative result may require further testing or clinical evaluation.
Positive: Pathogenic variant detected – confirms diagnosis of BLS2A
Negative: No pathogenic variants detected – BLS2A unlikely but not ruled out
Variant of uncertain significance (VUS) – requires further investigation and genetic counseling
⚠️ When to Consult a Doctor:

Consult a doctor if you experience recurrent infections, delayed growth, or other symptoms of immunodeficiency, or if genetic testing results are positive or uncertain.

Limitations

  • May not detect all types of mutations, such as large deletions or intronic variants
  • Requires genetic counseling for interpretation
  • Results should be correlated with clinical findings

Risks & Considerations

  • Minimal risk from blood draw, such as bruising or infection
  • Psychological impact of genetic results
  • Potential for uncertain results requiring further testing

Interfering Factors

  • Sample contamination or degradation
  • Insufficient DNA quantity or quality
  • Technical errors in sequencing

Compare With Similar Tests

TestCIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic TestFlow Cytometry for MHC-II ExpressionSanger Sequencing of CIITA Gene
ComparisonCIITA Gene Bare lymphocyte syndrome, type 2, complementation group A NGS Genetic Test

Frequently Asked Questions

What is the CIITA Gene BLS2A NGS Genetic Test?
It is a genetic test that uses next-generation sequencing to detect mutations in the CIITA gene, which cause Bare Lymphocyte Syndrome Type 2A, a rare immunodeficiency disorder.
Why is this test recommended?
It is recommended for individuals with recurrent infections, delayed growth, or other symptoms suggestive of BLS2A, or for those with a family history of the condition.
How is the test performed?
A blood sample or extracted DNA is analyzed using NGS technology to sequence the CIITA gene and identify pathogenic variants.
What sample is required for the test?
Blood, extracted DNA, or one drop of blood on an FTA card can be used.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
What does a positive result mean?
A positive result confirms the presence of pathogenic mutations in the CIITA gene, diagnosing BLS2A and guiding treatment.
What are the risks of the test?
Risks are minimal, including slight discomfort from blood draw and potential psychological impact of results.
Is the test covered by insurance?
Coverage depends on your insurance plan; it is not typically covered under government schemes like PMJAY or CGHS.
Can the test be done at home?
Yes, free home sample collection is available for online bookings across India.
What is the cost of the test?
The test costs INR 20,000, with a special discounted price available.
How accurate is the test?
NGS-based testing is highly accurate for detecting genetic mutations, but results should be interpreted in clinical context with genetic counseling.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.